But but but but but $2,000,000 cash on hand? Oh....yup!

CBTC! WE NEED NEWS HERE MANAGEMENT! THANKS!

C'MON $.75!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Again, not true at all. Thanks for posting. EOM good luck

First Quarter 2020 Highlights

Consolidated quarterly year-over-year growth in Net Sales of 75% to surpass $9 Million for Q1 2020
Prescriptions filled surpasses 134,000 in Q1 2020, up 59% versus Q1 2019
March 2020 set new Company record for monthly prescriptions filled
340B Agency Revenue jumped 76% (vs Q1 2019) to nearly 200,000
Net Loss of $795 K almost entirely attributable to PBM fees, with Q1 impact exaggerated due to seasonality of performance reimbursements
During the earnings call, Mars discussed dynamics important to interpreting the Company’s Q1 data and outlined a series of additional initiatives and projects currently underway that will further improve the Company’s financial performance and competitive positioning in 2020.

Progressive Care Reports June 2020 Performance Data: Preliminary Q2 Sales Up 33% to $9.32M
BY GlobeNewswire
— 7:00 AM ET 07/27/2020
Read Full Release

MIAMI, FL, July 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for June 2020, along with preliminary fiscal Q2 performance data, both of which demonstrate a continued robust trend of growth in sales, prescriptions, 340B income, and COVID- 19 testing service revenues.

Consolidated monthly gross sales across all locations during the month of June totaled $3.35 million, representing monthly sequential growth of 12% compared to May 2020
Consolidated preliminary sales for the three months ended June 30, 2020, totaled $9.32 million, representing quarterly year-over-year growth of 33.2%
Prescriptions filled during the month of June came in at 44,251, representing monthly sequential growth of 11% compared to May 2020
340B claim processing from FQHCs produced roughly $229K in net income, up over 80% on a monthly sequential basis
Expanded COVID-19 testing service to additional counties with strong demand, additional expansion underway
PharmcoRx locations performing COVID-19 tests:

“With strong cash levels in place, multiple scalable growth strategies underway, and core trends continuing to support strong expectations for the second half of the year, we believe we are poised to capitalize on opportunities for further growth in the months ahead.”

The Company continues to pursue increasing efficiency in its core pharmacy services business while establishing multiple technology solutions that present more scalable long-term growth potential, including nationwide healthcare data analytics. Looking ahead, management believes Progressive Care ( RXMD
Loading...
Loading...
) will benefit from new client acquisition on a national level in its data analytics strategy as well as new patient and provider market share gains due to its continued leadership in contactless same-day prescription delivery service.

MIAMI, FL, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. ( RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for July 2020, which continued to demonstrate a trend of robust growth in sales, prescriptions, and 340B income in both sequential monthly and year-over-year terms.

July was another strong month for Progressive Care ( RXMD
Loading...
Loading...
), featuring the continued emergence of our 340B strategy and a strong contribution from our ClearMetRx data analytics subsidiary,” commented Alan J. Weisberg, Interim CEO and Chairman of the Board of Progressive Care ( RXMD ).

Total 340B claim submissions booked in July grew to almost $3 million*

340B claim processing from 340B covered entities produced roughly $473K in revenue in July 2020, up 106% on a monthly sequential basis. This includes ClearMetRx third party administrator fees of over $146,000

July set a new all-time Company record for total prescriptions filled

Prescriptions filled during the month of July was 47,573, representing monthly sequential growth of 8% compared to June 2020, and 3% year-over-year growth compared to July 2019

Consolidated monthly gross sales across all locations during the month of July totaled $3.62 million, representing monthly sequential growth of 8% compared to June 2020, and 7% year-over-year growth compared to July 2019

Yup! Scooping away here! RXMD!

Progressive Care Reports July 2020 Performance Data: $3.62M in Gross Sales, and 106% Monthly Growth in 340B Income

2020 = $40+ MILLION REVENUES!!!!!!!!!!!!!!!!!!

Based on our past 10 day average and daily a few months ago. Since the CC there has been bigger volume daily!

Volume is still way up today....lots of buying going on....

The Company continues to pursue increasing efficiency in its core pharmacy services business while establishing multiple technology solutions that present more scalable long-term growth potential, including nationwide healthcare data analytics. Looking ahead, management believes Progressive Care ( RXMD
Loading...
Loading...
) will benefit from new client acquisition on a national level in its data analytics strategy as well as new patient and provider market share gains due to its continued leadership in contactless same-day prescription delivery service.

MIAMI, FL, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. ( RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for July 2020, which continued to demonstrate a trend of robust growth in sales, prescriptions, and 340B income in both sequential monthly and year-over-year terms.

“July was another strong month for Progressive Care ( RXMD
Loading...
Loading...
), featuring the continued emergence of our 340B strategy and a strong contribution from our ClearMetRx data analytics subsidiary,” commented Alan J. Weisberg, Interim CEO and Chairman of the Board of Progressive Care ( RXMD
Loading...
Loading...
).

Total 340B claim submissions booked in July grew to almost $3 million*

340B claim processing from 340B covered entities produced roughly $473K in revenue in July 2020, up 106% on a monthly sequential basis. This includes ClearMetRx third party administrator fees of over $146,000

July set a new all-time Company record for total prescriptions filled

Prescriptions filled during the month of July was 47,573, representing monthly sequential growth of 8% compared to June 2020, and 3% year-over-year growth compared to July 2019

Consolidated monthly gross sales across all locations during the month of July totaled $3.62 million, representing monthly sequential growth of 8% compared to June 2020, and 7% year-over-year growth compared to July 2019

Progressive Care Reports July 2020 Performance Data: $3.62M in Gross Sales, and 106% Monthly Growth in 340B Income

Same here. I'm long and in no hurry!

$.75 will take some.......then let the rest ride!!!!!!

NETE/RXMD lovely! Something big coming!!!

This is a huge deal!!!

Let's wait for the actual play here bud. We will hear something soon!

Glad you can also feel the excitement growing here!!! YES!

We are getting close!!!! Excitement grows!

Are we at $1.00+++ yet?

WE ARE AUDITED!!!! BOOM!!!

Lot's of new eyes here..welcome!

HEAVY VOLUME AND BUYING! CONGRATS!